Pharmaceutical

Opinion: In defense of being ‘Cali sober’

Hardcore proponents of abstinence-based recovery, such as Alcoholics Anonymous, ...

STAT+: Just how vulnerable is Medicare drug negotiation...

A new report suggests there are at least some parts of the law setting up Medica...

Valneva seeks Health Canada approval for chikungunya va...

The single-shot vaccine is intended for persons aged 18 years and above.

Roche Canada and pCPA conclude talks for Vabysmo eye th...

Vabysmo helps treat neovascular (wet) age-related macular degeneration (AMD) and...

Sun Pharma and Philogen sign licence agreement for anti...

Sun Pharma will commercialise Nidlegy in three countries to treat skin cancers.

Early signals suggest oral SERD’s potential for more br...

The company is presenting exploratory results at ASCO, which demonstrates new us...

US companies drive 2023 drug launches positioned for bl...

Notably, American pharmaceutical mega-cap companies take the lead, with 80% repr...

AION Labs and BioMed X launch sixth challenge for AI-dr...

The startup will utilise cutting edge methods to accelerate drug discovery resea...

Catalent CEO drops FY2023 revenue forecast by $450m aft...

In an investor call on 19 May, Catalent reduced its annual net revenue forecast ...

Abiogen acquires EffRx to fortify bone disease portfolio

The Italian pharmaceutical company Abiogen Pharma acquired Effrx Pharmaceuticals...

AstriVax received €2.5 million government grant for the...

The Flemish government grant adds on past seed funding that will be used to move...

SK Bioscience gains UK authorisation for SKYCovion Covi...

SKYCovion was created in collaboration with GSK's pandemic adjuvant and is suita...

Opinion: More young people should be getting their chol...

National guidelines around screening and treating cholesterol in young adults ne...

STAT+: Omada tackles obesity drugs, Boston Scientific n...

In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity dr...

STAT+: Will Medicare cover it? Drugs like Aduhelm are c...

Medicare’s coverage decision has revived longstanding questions about how the fe...

Who’s acquiring who? Virtual care M&A activity in the p...

Analysis of the key themes driving M&A activity reveals that virtual care accoun...